Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.840
-0.220 (-10.68%)
Dec 5, 2025, 4:00 PM EST - Market closed

Artelo Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2021 2020 - 2016
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 2020 - 2016
Net Income
-12.49-9.83-9.29-10.08-12.11-7.44
Upgrade
Other Amortization
0.14-----
Upgrade
Loss (Gain) From Sale of Investments
-0.03-0.28-0.64-0.21-0.020
Upgrade
Stock-Based Compensation
0.980.821.022.462.81.53
Upgrade
Other Operating Activities
-0.040.030.040.040.030.01
Upgrade
Change in Accounts Payable
3.220.480.270.021.5-0
Upgrade
Change in Other Net Operating Assets
0.060.430.39-0.24-0.21-0.24
Upgrade
Operating Cash Flow
-8.18-8.35-8.21-8.01-8-6.14
Upgrade
Investment in Securities
0.57.773.512.96-30.1-3.44
Upgrade
Investing Cash Flow
0.257.773.512.96-30.1-3.44
Upgrade
Short-Term Debt Issued
-----0
Upgrade
Total Debt Issued
0.74----0
Upgrade
Short-Term Debt Repaid
------0.01
Upgrade
Total Debt Repaid
-----0-0.01
Upgrade
Net Debt Issued (Repaid)
0.74----0-0.01
Upgrade
Issuance of Common Stock
4.580.110.57-54.7914.12
Upgrade
Financing Cash Flow
5.320.110.57-54.7814.11
Upgrade
Foreign Exchange Rate Adjustments
-0.03-0.010.06-0.22-0.08-0.05
Upgrade
Net Cash Flow
-2.64-0.48-4.07-5.2716.64.49
Upgrade
Free Cash Flow
-8.18-8.35-8.21-8.01-8-6.14
Upgrade
Free Cash Flow Per Share
-12.41-15.54-16.64-16.96-21.53-29.59
Upgrade
Levered Free Cash Flow
-3.47-4.7-4.64-4.31--3.18
Upgrade
Unlevered Free Cash Flow
-3.49-4.7-4.64-4.3--3.18
Upgrade
Change in Working Capital
3.280.910.66-0.221.29-0.24
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.